Le Lézard
Classified in: Health
Subject: TRI

Apollo Proton Cancer Centre successfully performs Asia's 1st Brain Bypass Surgery on twin children with Moya Moya Disease


CHENNAI, India , Dec. 7, 2022 /PRNewswire/ -- Apollo Proton Cancer Centre (APCC) recently performed Asia's first brain bypass surgery on twin 8-year-old children from the Netherlands. The integration of advanced technology and expertise at APCC helped the children to undergo surgery and recover quickly.

The first case to be witnessed in Asia of Moya Moya disease -- a rare blood vessel (vascular) disorder in which the carotid artery in the skull is blocked or narrowed -- reduces blood flow to the brain. The condition was diagnosed in eight-year-old twin girls. Over the years, one of the twins developed vague symptoms like jerky movements in the right hand and leg. The requested MRI scan of the brain showed that the blood supply to the brain was significantly compromised on both sides of the brain, especially on the left. These episodes originally thought to be as seizures were a form of multiple mini-strokes often called limb-shaking epilepsy, which signifies compromised blood circulation to the brain. Since the girls were twins, both were scanned and showed similar MRI findings. The children were examined by a senior neuro-physician, who diagnosed this condition as Moya Moya disease.

The neuro-sciences team led by Dr. Roopesh Kumar, Senior Consultant, Neurosurgeon, APCC further examined the children using MRI brain perfusion. The findings were almost similar in both twins and the left side was more affected than the right. Due to the lack of medicines for the disease, the doctors offered surgical intervention via a brain bypass surgery wherein the blood supply from the skin of the head would be diverted into the brain through a window created on the skull bone. The surgery, STA-MCA bypass, was performed initially for the symptomatic child. And on the second day, the other child also underwent a similar procedure.

Dr. Roopesh Kumar, Senior Consultant, Neurosurgeon, Apollo Proton Cancer Centre, said "The surgery to ensure good blood flow in the left brain and reduce the chances of strokes to a minimum, was successful and was well adapted to the body. The timely decision to perform this complex surgery helped in saving lives at the right time. At APCC, high-risk cases are managed in a specialised tertiary centre with excellent facilities. The advanced surgical techniques and availability of technology in combination with expertise improves the chances of saving a patient's life even in critical complications."

Photo - https://mma.prnewswire.com/media/1962604/APCC.jpg

 


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: